Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...